Anti-cancer compound and pharmaceutical composition comprising it

Abstract

The invention relates to the compound of formula (I): more particularly in its levogyratory form (la), particularly that exhibiting the optical rotation [a]D- -38.6+0.7 at a concentration of 0.698 mg / ml in methanol. The compound may exist in the form of a base or an addition salt with an acid, particularly a pharmaceutically acceptable acid. This compound is a selective inhibitor of Aurora A and B kinases. It can be used as an anti-cancer ingredient.